Last reviewed · How we verify

NCT05242393

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

Recruiting now Last updated 8 August 2025
What this trial tests

trial testing No intervention is planned in Stroke, Ischemic in 250 participants. Currently enrolling.

Timeline
1 May 2018
Primary endpoint
30 January 2026
31 December 2026

Quick facts

Lead sponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment250
Start date1 May 2018
Primary completion30 January 2026
Estimated completion31 December 2026
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

Who can join

Adults 18 to 80, any sex, with Stroke, Ischemic or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sleep disorders as both risk factors for, and a consequence of, stroke: A narrative review.
    Mayer-Suess L, Ibrahim A, Moelgg K, Cesari M, et al · · 2024 · cited 25× · PMID 37885093 · DOI 10.1177/17474930231212349

Verify or expand the search:

Other trials of No intervention is planned

Trials testing the same drug.

Other recruiting trials for Stroke, Ischemic

Currently open trials in the same condition.

Other Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242393.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing